Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Tci Gene's change in inventory for the quarter that ended in Jun. 2026 was NT$-1.5 Mil. It means Tci Gene's inventory
increased by NT$1.5 Mil
from Dec. 2025 to Jun. 2026 .
Tci Gene's change in inventory for the fiscal year that ended in Dec. 2025 was NT$25.1 Mil. It means Tci Gene's inventory
declined by NT$25.1 Mil
from Dec. 2024 to Dec. 2025 .
Days Inventory indicates the number of days of goods in sales that a company has in the inventory.
Tci Gene's Days Inventory for the quarter that ended in Jun. 2026 was 69.25.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Tci Gene's Inventory Turnover for the quarter that ended in Jun. 2026 was 2.64.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Tci Gene's Inventory-to-Revenue for the quarter that ended in Jun. 2026 was 0.16.
3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Tci Gene's Inventory to Revenue for the quarter that ended in Jun. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Tci Gene Change In Inventory Related Terms
Tci Gene Change In Inventory Historical Data
* Premium members only.
The historical data trend for Tci Gene's Change In Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.
Change In Inventory for the trailing twelve months (TTM) ended in Jun. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was NT$10.2 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Change In Inventory of NT$10.2 Mil mean?
Tci Gene (ROCO:6879) has a Change In Inventory of NT$10.2 Mil as of Jun. 2026. Change in Inventory is the difference between current-period inventory and past-period inventory. View historical data for Tci Gene and its competitors.
Is Tci Gene's Change In Inventory too high?
Tci Gene's current Change In Inventory is NT$10.2 Mil. Overall, Tci Gene has a GF Score™ of 67/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Tci Gene's Change In Inventory compare to VRTX and REGN?
Tci Gene's Change In Inventory of NT$10.2 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Change In Inventory for a Biotechnology company?
A good Change In Inventory depends on the Biotechnology industry context. However, Change In Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Change In Inventory mean?
A high Change In Inventory can signal that a stock is expensive relative to its fundamentals. Change in Inventory is the difference between current-period inventory and past-period inventory. View historical data for Tci Gene and its competitors. Tci Gene's current Change In Inventory is NT$10.2 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Tci Gene stock overvalued right now?
Based on GuruFocus' analysis, Tci Gene (ROCO:6879) is currently considered Fairly Valued. The stock's GF Value™ is NT$35.63, compared to a current price of NT$35.55 — trading 0.2% below its estimated fair value. The current Change In Inventory is NT$10.2 Mil. Tci Gene's overall GF Score™ is 67/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Change In Inventory calculated?
Change In Inventory is calculated from a company's financial statements. For Tci Gene (ROCO:6879), the current Change In Inventory is NT$10.2 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Tci Gene (ROCO:6879) Overvalued in 2026?
Based on GuruFocus' analysis, Tci Gene stock appears to be undervalued.
The current stock price of NT$35.55 is trading 0.2% below its estimated GF Value™ of NT$35.63.
GuruFocus considers Tci Gene to be Fairly Valued.
Key valuation signals for ROCO:6879:
Change In Inventory: NT$10.2 Mil
GF Value™: NT$35.63 vs. price of NT$35.55 (0.2% below fair value)
No single metric tells the full story. See the ROCO:6879 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Tci Gene Inc provides precision preventive medicines in Taiwan. It is the first to introduce the concept of precision preventive medicine with Predict prediction, Prevent prevention, and Personal Treatment personalized health management measures.
67GF Score
Get the complete analysis for ROCO:6879
Change In Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:6879 has been successfully added to your 
